{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260504905593/en/Guardant-Health-Receives-FDA-Approval-for-Guardant360%C2%AE-CDx-as-a-Companion-Diagnostic-for-Arvinas-and-Pfizer%E2%80%99s-VEPPANU-vepdegestrant-for-Patients-with-ERHER2--Advanced-Breast-Cancer-with-ESR1-Mutations", "message": "News view counter 699651 successfully enlarged"}